IMP3 and breast carcinoma: The EGFR signaling pathway was shown to regulate the expression of IMP3 and is involved in IMP3 promotion of breast cancer cell migration and invasion by up-regulation of CD164 and matrix metalloproteinase 9 (MMP9) [24].